Purpose: To describe the histologic spectrum and clinical characteristics of patients with
neuroepithelial tumors and drug‐resistant epilepsy and to analyze clinical data and …

We identified 39 patients with chronic epilepsy (seizures≥ 2 years) proven to have primary
brain tumors. These cases represent∼ 12% of the surgery cases for epilepsy in the same …

The semi-benign nature of diffuse astrocytomas is characterized by an increased risk for
tumor recurrence and malignant transformation. In patients with intractable seizures …

Every fourth patient submitted to epilepsy surgery suffers from a brain tumor.
Microscopically, these neoplasms present with a wide-ranging spectrum of glial or glio …

OBJECTIVE: Surgical treatment in patients with brain tumors and medically intractable
epilepsy is aimed at the removal of the neoplasm and complete seizure control. However, an …

Epilepsy in neuroepithelial tumors is highly prevalent. Neurogliomas (dysembryoplastic
neuroepitheliomas [DNETs] and gangliogliomas) have a seizure incidence of 80–100%, low …

The surgical treatment of chronic epilepsies is increasing rapidly. Here we report the
histopathologic findings in 216 consecutive surgical specimens of patients with chronic …

Object Seizures are a common presenting symptom and cause of morbidity for patients with
malignant astrocytomas. The authors set out to determine preoperative seizure …

The surgical treatment of chronic epilepsies is increasing rapidly and involves
neuropathologists in the care of patients with chronic and medically intractable seizure …

The present study intends to identify factors that predict postoperative clinical outcome in
patients with gangliogliomas (GG) and dysembryoplastic neuroepithelial tumors (DNT). We …